Electrophysiological Signatures of Distinct Working Memory Subprocesses That Predict Long-term Memory Success
Launched by UNIVERSITY OF CHICAGO · May 26, 2023
Trial Information
Current as of November 02, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This observational study at the University of Chicago is trying to understand how brain activity, measured with EEG, relates to working memory and how that brain activity predicts long-term memory. Healthy young adults will perform a memory task where they view pictures and later decide if they’ve seen them before, rating their confidence. The researchers will look at how brain signals during the task relate to which pictures people remember later, using computer methods to see if patterns can predict memory success. There is no treatment or drug involved.
Eligibility is for adults aged 18–35 who have normal or corrected vision and are fluent in English. About 96 people are planned to participate. If eligible, you’ll join at the University of Chicago in Chicago, with sessions totaling about three hours. You’ll view pictures, have your brain activity recorded, and then complete the memory test, including reporting whether items are old or new. The study plans to share de-identified data publicly after publication. If you want more details or to learn about joining, you can contact the study team led by researchers including Megan deBettencourt, Ed Vogel, and Ed Awh.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • normal or corrected to normal vision
- Exclusion Criteria:
- • non-fluent in English
About University Of Chicago
The University of Chicago is a prestigious research institution renowned for its commitment to advancing medical science through innovative clinical trials. With a robust infrastructure that supports multidisciplinary collaboration, the University actively engages in cutting-edge research across various therapeutic areas. Its dedicated team of experienced investigators and state-of-the-art facilities enable the University of Chicago to conduct rigorous clinical studies aimed at improving patient outcomes and translating scientific discoveries into tangible healthcare solutions. The institution prioritizes ethical standards and patient safety, ensuring that all trials adhere to the highest regulatory guidelines and best practices in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Patients applied
Trial Officials
Megan deBettencourt
Principal Investigator
University of Chicago
Ed Vogel
Principal Investigator
University of Chicago
Ed Awh
Principal Investigator
University of Chicago
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported